Company Filing History:

7 out of 637

Bristol-myers Company

patents

5 out of 3,681

Bristol-myers Squibb Compnay

patents

Years Active: 1983-1994

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5332574 - Compounds produced by a strain of Streptomyces exfoliatus (1994-07-26),

2. 5114920 - BU-3292T antibiotics (1992-05-19),

3. 5093248 - BU-3862T antitumor antibiotic (1992-03-03),

4. 5037836 - BU-4146T antibiotic (1991-08-06),

5. 5002959 - BU-4146T antibiotic (1991-03-26),

6. 4912133 - BU-3862T antitumor antibiotic (1990-03-27),

7. 4883758 - Biologically pure culture of the microorganism Streptomycas (1989-11-28),

8. 4833079 - Process for producing 3,7-dihydroxytropolone and antitumor use thereof (1989-05-23),

9. 4572895 - Process for preparing an antibiotic complex by culturing actinomyces (1986-02-25),

10. 4533631 - Fermentation process for preparation of antibiotic Bu-2517 (1985-08-06),

11. 4518589 - BBM-2478 Antibiotic complex (1985-05-21),

12. 4409210 - Antibiotic compound (1983-10-11),

Title: Koko Sugawara: Innovator in Antimicrobial Compounds

Introduction

Koko Sugawara is a prominent inventor based in Saitama, Japan. She has made significant contributions to the field of microbiology and pharmaceuticals, holding a total of 12 patents. Her work primarily focuses on the development of antimicrobial compounds and antibiotics.

Latest Patents

Among her latest patents are the compounds produced by a strain of Streptomyces exfoliatus. These include active compounds BU-4726G-A and BU-4726G-B, which contain a quinone chromophore and hydroquinone chromophore, respectively. These compounds are produced through the fermentation of Streptomyces exfoliatus AA4510 and possess antimicrobial properties along with K.sub.ATP channel blocking activities. Additionally, she has developed new antibiotics designated BU-3292T A and B, which exhibit antimicrobial activity and inhibit tumor growth in experimental animal systems. BU-3292T A is produced by fermentation of Elytrosporangium sp. nov. (ATCC 53784), while BU-3292T B is obtained by oxidizing BU-3292T A.

Career Highlights

Koko Sugawara has worked with notable companies such as Bristol-Myers Company and Bristol-Myers Squibb Company. Her innovative research has led to advancements in the development of effective antimicrobial agents.

Collaborations

She has collaborated with esteemed colleagues, including Masataka Konishi and Koji Tomita, to further her research and development efforts.

Conclusion

Koko Sugawara's contributions to the field of antimicrobial compounds and antibiotics highlight her role as a leading inventor. Her innovative work continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.